Here below are the publications (1) participated by Davide Rossi along with Martin R. Faderl (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch
Davide Rossiis currently collaborating with
Istituto Oncologico di Ricerca (IOR) (Rif. IOR)
Via Francesco Chiesa 5
6500 Bellinzona
Davide Rossi
on behalf of
Istituto Oncologico di Ricerca (IOR) USI (Rif. IOR)
is currently participating in the Research Group
Experimental Hematology
as Group Leader [Rif. 55110]
on behalf of
Istituto Oncologico di Ricerca (IOR) USI (Rif. IOR)
is currently participating in the Research Group
Experimental Hematology
as Group Leader [Rif. 55110]
Davide Rossi
on behalf of
Istituto Oncologico Svizzera Italiana (IOSI) EOC (Rif. IOSI)
is currently Research Program Leader [Rif. 50110] for
A Phase II Study to Evaluate the Efficacy and Safety of MK 1026 in Participants with hematologic malignancies (Rif. 22000 202407)
on behalf of
Istituto Oncologico Svizzera Italiana (IOSI) EOC (Rif. IOSI)
is currently Research Program Leader [Rif. 50110] for
A Phase II Study to Evaluate the Efficacy and Safety of MK 1026 in Participants with hematologic malignancies (Rif. 22000 202407)